- Home
- PLYM vs MDXG Comparison
PLYM vs MDXG Comparison
Compare PLYM & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLYM
- MDXG
- Stock Information
- Founded
- PLYM 2011
- MDXG 2006
- Country
- PLYM United States
- MDXG United States
- Employees
- PLYM N/A
- MDXG N/A
- Industry
- PLYM Real Estate Investment Trusts
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- PLYM Real Estate
- MDXG Health Care
- Exchange
- PLYM Nasdaq
- MDXG Nasdaq
- Market Cap
- PLYM 981.1M
- MDXG 1.0B
- IPO Year
- PLYM 2017
- MDXG N/A
- Fundamental
- Price
- PLYM $21.96
- MDXG $6.67
- Analyst Decision
- PLYM Hold
- MDXG Buy
- Analyst Count
- PLYM 7
- MDXG 1
- Target Price
- PLYM $20.83
- MDXG $12.00
- AVG Volume (30 Days)
- PLYM 828.2K
- MDXG 688.8K
- Earning Date
- PLYM 11-05-2025
- MDXG 10-29-2025
- Dividend Yield
- PLYM 4.46%
- MDXG N/A
- EPS Growth
- PLYM 439.08
- MDXG N/A
- EPS
- PLYM 2.89
- MDXG 0.21
- Revenue
- PLYM $171,801,000.00
- MDXG $363,774,000.00
- Revenue This Year
- PLYM $1.88
- MDXG $12.68
- Revenue Next Year
- PLYM $9.24
- MDXG $8.18
- P/E Ratio
- PLYM $7.44
- MDXG $30.99
- Revenue Growth
- PLYM N/A
- MDXG 6.85
- 52 Week Low
- PLYM $12.70
- MDXG $5.59
- 52 Week High
- PLYM $22.65
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- PLYM 59.07
- MDXG 41.72
- Support Level
- PLYM $20.97
- MDXG $6.41
- Resistance Level
- PLYM $22.60
- MDXG $7.35
- Average True Range (ATR)
- PLYM 0.38
- MDXG 0.25
- MACD
- PLYM -0.20
- MDXG -0.05
- Stochastic Oscillator
- PLYM 60.63
- MDXG 26.60
About PLYM Plymouth Industrial REIT Inc.
Plymouth Industrial REIT Inc is a full-service, vertically integrated, self-administered, and self-managed Maryland corporation. It is focused on the acquisition, ownership, and management of single and multi-tenant Class B industrial properties, including distribution centers, warehouses, and light industrial properties, located in secondary and primary markets across the United States. The company has one reportable segment, which is Industrial properties. The majority of its property portfolio is spread across Florida, Ohio, Indiana, Tennessee, Illinois and Georgia, among others. It receives income from the rental revenue through its properties.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.